Sharing the transformative power of AI-Immunology™ 🙌 Yesterday, Evaxion’s founder and chief AI officer, Andreas Holm Mattsson, took center stage today at the AI-driven Drug Discovery Summit. Addressing an audience of over 200 leaders from pharma and biotech, Andreas shed light on the game-changing potential of our AI-Immunology™ platform, emphasizing its role in reshaping vaccine development to be faster, cost-effective, and safer💡 Today, he was honorably selected to act as Chair of the morning session🪑 At Evaxion, we take pride in having already demonstrated the precision and predictive power of our AI-Immunology™ platform in oncology and infectious diseases. This seamless integration of AI predictions with both pre-clinical and clinical outcomes is a testament to the power of our proprietary platform and the promise it holds for helping patients globally 🌍💙 Curious to hear more? Dive deeper into the world of AI-Immunology™ and uncover our diverse pipeline products by clicking the link below! 👇 🔗 https://lnkd.in/dfTVx4xQ #AI #AIDrivenDrugDevelopment #Immunotherapy #Biotech
